The discovery of this pathway sheds light on the molecular underpinnings of metabolic deregulation in ESCC and suggests the STIP1‐AHCY‐LDHA axis may serve as a prognostic biomarker and present a novel therapeutic target opportunity. Here, AHCY is linked to esophageal squamous cell carcinoma.